Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.19

+1.8%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2347)	12/19/2000 7:50:52 PM
From: Miljenko Zuanic	Read Replies (1) of 52153

<<Interesting to see what a few of the managers are up to:>> They are up to the shit with theory about what was, what is, and what is coming. <<And after some promising reports from the human genome project in March, biotechs have taken off. >> Human genome project started 20-years ago, and several bios started to benefit from current results. Completion of the gene-map was hype, tools to those who can not look back and said: I was wrong. I am sorry, but I do not see anything interesting in what they see, because they see less than we do. Only they have more money, our money, to convince other (by manipulation) that they see correct. So they are now looking for excuse for their big and secure bets. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next